Successful Construction Of Eukaryotic Plasmids Containing HBV C Genotype
Oct 1st 2008Drug InformationGastroIntestinal / Gastroentorology
HBV infection remains a major health problem in the world. Several data have revealed that lamivudine can efficiently promote the treatment of hepatitis B. However, a long-term treatment of lamivudine leads to the emergence of lamivudine-resistant mutants (YMDD mutants), which hampers the anti-HBV therapy. Therefore, researches related to HBV lamivudine-resistant mechanism has been of great significance.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
